Laboratorio Farmaceutico Erfo Future Growth
Future criteria checks 3/6
Laboratorio Farmaceutico Erfo is forecast to grow earnings and revenue by 11.4% and 12.5% per annum respectively. EPS is expected to grow by 9.6% per annum. Return on equity is forecast to be 10.2% in 3 years.
Key information
11.4%
Earnings growth rate
9.6%
EPS growth rate
| Personal Products earnings growth | 8.1% |
| Revenue growth rate | 12.5% |
| Future return on equity | 10.2% |
| Analyst coverage | Low |
| Last updated | 23 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 9 | 1 | 1 | 2 | 1 |
| 12/31/2025 | 7 | 1 | 1 | 2 | 1 |
| 12/31/2024 | 7 | 1 | 1 | 1 | 1 |
| 12/31/2023 | 6 | 1 | 0 | 1 | N/A |
| 9/30/2023 | 6 | 1 | -1 | 1 | N/A |
| 6/30/2023 | 5 | 1 | -1 | 1 | N/A |
| 3/31/2023 | 5 | 1 | -1 | 1 | N/A |
| 12/31/2022 | 5 | 1 | 0 | 1 | N/A |
| 9/30/2022 | 5 | 1 | N/A | N/A | N/A |
| 6/30/2022 | 5 | 1 | N/A | N/A | N/A |
| 3/31/2022 | 5 | 1 | N/A | N/A | N/A |
| 12/31/2021 | 5 | 1 | 2 | 2 | N/A |
| 12/31/2020 | 4 | 1 | 1 | 1 | N/A |
| 12/31/2019 | 5 | 1 | N/A | N/A | N/A |
| 12/31/2018 | 4 | 1 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ERFO's forecast earnings growth (11.4% per year) is above the savings rate (2.4%).
Earnings vs Market: ERFO's earnings (11.4% per year) are forecast to grow faster than the Italian market (6.8% per year).
High Growth Earnings: ERFO's earnings are forecast to grow, but not significantly.
Revenue vs Market: ERFO's revenue (12.5% per year) is forecast to grow faster than the Italian market (3.9% per year).
High Growth Revenue: ERFO's revenue (12.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ERFO's Return on Equity is forecast to be low in 3 years time (10.2%).